Evidence map›Paper›PMID 35517443›Full record

ArticleRSC advances2020

Novel quercetin and apigenin-acetamide derivatives: design, synthesis, characterization, biological evaluation and molecular docking studies.

Daniel Isika, Mustafa Çeşme, Francis J Osonga, Omowunmi A Sadik

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Investigation of the ability of 3-((4-chloro-6-methyl pyrimidin-2-yl)amino) isobenzofuran-1(3H)-one to bind to double-stranded deoxyribonucleic acid.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Daniel IsikaDepartment of Chemistry and Environmental Science, Sensors Mechanisms Research & Technology (The SMART Center), New Jersey Institute of Technology 161 Warren Street, University Heights Newark NJ 07102 USA sadik@njit.edu.
Mustafa ÇeşmeDepartment of Chemistry, Faculty of Art and Sciences, Kahramanmaras Sutcu Imam University Kahramanmaras 46040 Turkey.
Francis J OsongaDepartment of Chemistry and Environmental Science, Sensors Mechanisms Research & Technology (The SMART Center), New Jersey Institute of Technology 161 Warren Street, University Heights Newark NJ 07102 USA sadik@njit.edu.
Omowunmi A SadikDepartment of Chemistry and Environmental Science, Sensors Mechanisms Research & Technology (The SMART Center), New Jersey Institute of Technology 161 Warren Street, University Heights Newark NJ 07102 USA sadik@njit.edu.
Start Making A Reader Today · USKahramanmaraş Sütçü İmam University · TRNewark Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoids exhibit essential but limited biological properties which can be enhanced through chemical modifications. In this study, we designed, synthesized, and characterized two novel flavonoid derivatives, quercetin penta-acetamide (1S3) and apigenin tri-acetamide (2S3). These compounds were confirmed using (

Identifiers

PMID35517443
PMCPMC9055277
OpenAlexW3038251525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.